Reduced Port Laparoscopic Gastrectomy for Gastric Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorNanchong Central Hospital
About this trial
Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy
Eligibility criteria
Qualifiers
Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages.
Eastern Cooperative Oncology Group performance status of 0 or 1.
Adequate organ function.
Disqualifiers
Patients had distant metastasis.
oesophageal invasion of more than 3 cm.
Borrmann type 4 or large (more than 8 cm) type 3 carcinoma.
Previous chemotherapy or radiation therapy for any other malignancies.
Trial design
Treatments tested in this trial
- Reduced port laparoscopic gastrectomy
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov